2020
DOI: 10.3390/ijms21031050
|View full text |Cite
|
Sign up to set email alerts
|

Dexamethasone Treatment Increases the Intracellular Calcium Level Through TRPV6 in A549 Cells

Abstract: This study investigated the effect of dexamethasone (DEX) on intracellular calcium levels and the expressions of transient receptor potential cation channel subcomponent V member 6 (TRPV6), sodium-calcium exchanger 1 (NCX1), and plasma membrane calcium ATPase 1 (PMCA1) in A549 cells. The intracellular calcium level, by using the calcium indicator pGP-CMV-GCaMP6f, increased following DEX treatment for 6, 12, and 24 h in A549 cells. In addition, Rhod-4 assay after DEX treatment for 24 h showed that DEX increased… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
1
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 39 publications
(55 reference statements)
0
1
0
Order By: Relevance
“…D. The boxplot of the Silhouette coefficient.Next, we investigated the capacity of TREVI XMBD to capture subtle temporal dynamics in perturbed cells of the same cell type, aiming to discern nuanced changes. For this purpose, we utilized the A549 dataset, comprising cells derived from the human non-small cell lung cancer (NSCLC) cell line, treated with Dexamethasone (DEX), and sampled at three distinct time points (0, 1, and 3 hour)[18]. Employing multi-omics sequencing, the dataset probed the impact of DEX on the evolution and reprogramming of human NSCLC cells, a process characterized by gradual, subtle alternations in cellular genetic elements.…”
mentioning
confidence: 99%
“…D. The boxplot of the Silhouette coefficient.Next, we investigated the capacity of TREVI XMBD to capture subtle temporal dynamics in perturbed cells of the same cell type, aiming to discern nuanced changes. For this purpose, we utilized the A549 dataset, comprising cells derived from the human non-small cell lung cancer (NSCLC) cell line, treated with Dexamethasone (DEX), and sampled at three distinct time points (0, 1, and 3 hour)[18]. Employing multi-omics sequencing, the dataset probed the impact of DEX on the evolution and reprogramming of human NSCLC cells, a process characterized by gradual, subtle alternations in cellular genetic elements.…”
mentioning
confidence: 99%